Aromatase Inhibitor News and Research

RSS
Aromatase Inhibitors are drugs that prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy for postmenopausal women who have hormone-dependent breast cancer.
Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

Ribociclib plus endocrine therapy offers survival benefit for postmenopausal patients with metastatic breast cancer

Ribociclib plus endocrine therapy offers survival benefit for postmenopausal patients with metastatic breast cancer

KU researcher wins $1.25 million award to investigate the vital role of sex hormones in tissue repair

KU researcher wins $1.25 million award to investigate the vital role of sex hormones in tissue repair

Novel anti-hormonal therapy may be a new treatment option for early-stage breast cancer

Novel anti-hormonal therapy may be a new treatment option for early-stage breast cancer

Blood serum test can identify which breast cancer patients have slow-growing disease

Blood serum test can identify which breast cancer patients have slow-growing disease

Molecular imaging can predict response to novel metastatic breast cancer treatment

Molecular imaging can predict response to novel metastatic breast cancer treatment

Study shows association between chemotherapy benefit and menopausal status in breast cancer patients

Study shows association between chemotherapy benefit and menopausal status in breast cancer patients

Study uncovers the locus of male sexual desire in the brain

Study uncovers the locus of male sexual desire in the brain

Women with T1a breast cancers could benefit from hormone treatment

Women with T1a breast cancers could benefit from hormone treatment

Surgical delay does not lower overall survival of women with early-stage breast cancer

Surgical delay does not lower overall survival of women with early-stage breast cancer

Newer data confirms survival advantages, but also side effects for ribociclib in breast cancer

Newer data confirms survival advantages, but also side effects for ribociclib in breast cancer

Study provides new insight into neurofibromin-deficient ER+ breast cancer

Study provides new insight into neurofibromin-deficient ER+ breast cancer

Patient-reported outcomes linked to aromatase inhibitor adherence

Patient-reported outcomes linked to aromatase inhibitor adherence

10-year results from clinical trial of extended letrozole therapy for women with HR+ breast cancer

10-year results from clinical trial of extended letrozole therapy for women with HR+ breast cancer

Tart cherry reduces joint pain and sore muscles in some breast cancer patients, study shows

Tart cherry reduces joint pain and sore muscles in some breast cancer patients, study shows

Targeted breast cancer therapy shows 'encouraging' results

Targeted breast cancer therapy shows 'encouraging' results

Targeted therapy plus hormone therapy improves survival in premenopausal patients with advanced HR+ breast cancer

Targeted therapy plus hormone therapy improves survival in premenopausal patients with advanced HR+ breast cancer

FRAX tool useful in breast cancer patients treated with aromatase inhibitors

FRAX tool useful in breast cancer patients treated with aromatase inhibitors

FDA extends indication of metastatic breast cancer treatment to include male patients

FDA extends indication of metastatic breast cancer treatment to include male patients

Altering gut microbiome may be potential treatment option for PCOS

Altering gut microbiome may be potential treatment option for PCOS